Zoom and Chewy were Wall Street darlings over the last year, but this company quietly outdid them both with 370% returns…

It’s old news that the coronavirus forced more people to use Zoom for work meetings and that more people adopted pets and bought them food and treats on Chewy

And how the stock prices for both companies have climbed since last March.

Click to enlarge
But do you see that darker blue line in the chart above?

The one that shows a bigger gain (370%) than Zoom or Chewy?

No one is talking about this, but I know about one company that has made people more money than either of those work from home darlings…

And revenue is not going to slow down in a post-coronavirus world like some people are worried about with work from home stocks; sales are only going to keep increasing.

Because the company I know about operates in a market that was worth $17.5 billion in 2020 and is projected to climb to $41.5 billion by 2025.

That means those 370% gains are just an early preview of what to expect…but you don’t have long to act.

The secret that this is the best investment to make won’t stay a secret much longer.

Let me show you what company I’m talking about…

Boris Jordan Isn’t in the Cannabis Business. He’s in the Empire Business

Over the next decade in the United States, walking into a dispensary to buy a pack of pre-rolled joints will be just as commonplace as it is right now to go into a liquor store and buy a six-pack of beer.

Curaleaf Holdings Inc. (OTC: CURLF) Chairman Boris Jordan knows that, and he has been planning ahead to make sure his company is in the best position to make the most money as the U.S. is expected to become a $41.5 billion market by 2025.

Curaleaf wants to reach the 93% to 95% of U.S. households that don’t currently consume it. To do that, it will eventually become just a processor and manufacturer of cannabis products.

That will cut out the cost of grow operations, and it will also allow the company to focus more on its branding to stand out from the crowd.

“We’re making the products much more mainstream for our customer base – we’ll be no different than Coca-Cola or Frito-Lay,” Johnson said in an interview with Forbes.

The company already has operations in 23 states with a total of 101 dispensaries, making it one of the largest multi-state operators (MSOs). That’s a good start in reaching the 93% to 95% of U.S. households that aren’t currently consuming cannabis.

And as more states start to legalize, it’s going to expand across the country even more – organically and through strategic acquisitions.

So just like Starbucks or McDonald’s, Curaleaf will be everywhere its potential customers will be.

That’s why, as impressive as those 370% gains have been over the past year, that’s just an early taste of what you can expect as a CURLF shareholder.

In fact, I’ll be back next week with a report about how Curaleaf isn’t just dominating the U.S.

It’s going to conquer the world.

Editor’s Note: Until then, make sure you check out this new video report from chief investment strategist Shah Gilani, who is sharing his critical recommendations for protecting your profits and multiplying your returns in 2021 and beyond.

I’ll talk to you soon,

Danny Brody
Partner, RADD Capital


4 responses to “Forget Zoom and Chewy: This Stock Climbed 100% More Since the Coronavirus and Bigger Gains Are on the Way”

  1. im a small investor but i want to invest in the cannabis market, are there anymore penney cannabis companies you can recommend?

  2. yes sir have i noticed alot of store her in fl. althouh iam new at this they have fl. covered in storesand i notis ed that mouths ago in my portfolia. thanks john jordan

Leave a Reply

Your email address will not be published. Required fields are marked *